疾病研究と創薬のための人工結腸を開発(UC Irvine researchers invent a bioelectronic-integrated artificial colon for disease studies and drug screening)

ad

2025-10-15 カリフォルニア大学アーバイン校(UCI)

カリフォルニア大学アーバイン校(UCI)の研究チームは、バイオエレクトロニクス統合型人工大腸モデルを開発した。ゼラチンメタクリレートとアルギン酸を用いた3Dスキャフォールドにヒト大腸細胞と線維芽細胞を配置し、自然な腸構造と機能を再現。薬剤試験では抗がん剤5-FUへの耐性が実際の腫瘍と同様に高く、従来の培養法より生理的再現性が向上した。患者由来細胞を用いた個別化治療薬評価や動物実験代替への応用が期待される。成果は『Advanced Science』誌に掲載。

疾病研究と創薬のための人工結腸を開発(UC Irvine researchers invent a bioelectronic-integrated artificial colon for disease studies and drug screening)

<関連情報>

疾患の誘発とモニタリングのためのバイオエレクトロニクスを活用した3Dヒト大腸モデルの開発 Development of a 3D Human Colon Model Along with Bioelectronics for the Induction and Monitoring of Diseases

Jorge Alfonso Tavares-Negrete, Sahar Najafikoshnoo, Anita Ghandehari, Mozhgan Keshavarz, Quinton Smith, Armand Ahmetaj, Steven Zanganeh, Rahim Esfandyarpour
Advances Science  Published: 27 September 2025
DOI:https://doi.org/10.1002/advs.202506377

Abstract

Conventional in vitro and animal models do not reproduce the geometry, mechanics, or transport physics of the human colon, limiting their fidelity for disease studies and drug screening. A patient-derived, freeform reversible embedding of suspended hydrogels bioprinted three-dimensional (3D) in vivo mimicking human-colon model (3D-IVM-HC) is reported whose micro-computed tomography (CT) profile deviates by less than 4% from the original computed tomography template and spontaneously forms crypt-like invaginations with a median depth of 65 µm. The dual-layer gelatin methacrylate (GelMA)/alginate matrix matches native colonic stiffness (9–65 kPa) and sustains >95% cell viability with a 14-fold metabolic increase over 14 days. Caco-2 epithelia polarize within the lumen, form continuous Zonula occludens-1 (ZO-1) belts, and reach a transepithelial electrical resistance (TEER) of 68 ± 4 Ω cm2, values within the human ex vivo range. Finite-element simulations (FEM) parameterized with measured geometry and resistance predict water and nutrient fluxes within 80–99% of human explants. When HCT116 tumor spheroids are introduced, the construct yields a 5-fluorouracil (5-FU) half-maximal inhibitory concentration (IC5₀) of 540 ± 30 µm, an order of magnitude higher than a matched two-dimensional (2D) monolayer (42 ± 5 µm), mirroring clinical chemoresistance. Together, these benchmarks establish the 3D-IVM-HC as a physiologically faithful, non-animal model for probing colorectal biology and quantifying drug response.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました